Chinese Drug Makers Progress HER2 ADCs Amid Enhertu Dominance

 
• By Dexter Jie Yan
  
chase
Seven Chinese fast-followers of Enhertu are chasing the blockbuster drug in the domestic market. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D